The Global Burden of Stroke

Stroke

Volumn , Issue , 2011, Pages 279-289

  Strong, Kathleen ^a   Mathers, Colin ^b  

^a UNITAID   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882853046     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5478-8.10019-3     Document Type: Chapter

References (47)

1. Murray C.J.L., Lopez A.D. The global burden of disease 1996, Harvard School of Public Health, 1, Boston.
2. World Health Organization The global burden of disease: 2004 update 2008, World Health Organization, Geneva.
3. World Health Organization Global health risks: mortality and burden of disease attributable to selected major risks 2009, World Health Organization, Geneva.
4. World Bank World development report 1993. Investing in health 1993, Oxford University Press for the World Bank, New York.
5. Murray C.J.L., Lopez A.D. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020 1996, Harvard University Press, Cambridge.
6. Lopez A.D., Mathers C.D., Ezzati M., et al. Global burden of disease and risk factors 2006, Oxford University Press, New York.
7. Mathers C.D., Lopez A.D., Murray C.J.L. The burden of disease and mortality by condition: Data, methods and results for 2001. Global burden of disease and risk factors 2006, 45-240. Oxford University Press, New York. A.D. Lopez, C.D. Mathers, M. Ezzati, C.J.L. Murray, D.T. Jamison (Eds.).
8. Murray C.J.L. Rethinking DALYs. The global burden of disease 1996, 1-98. Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Cambridge. C.J.L. Murray, A.D. Lopez (Eds.).
9. World Health Organization World health report 2004: Changing history 2004, World Health Organization, Geneva.
10. Murray C.J.L., Ferguson B.D., Lopez A.D., et al. Modified logit life table system: Principles, empirical validation and application. Popul Stud 2003, 57(2):1-18.
11. Mathers C.D., Ma Fat D., Inoue M., et al. Counting the dead and what they died from: An assessment of the global status of cause of death data. Bull World Health Organ 2005, 83(March):171-177.
12. Salomon J.A., Murray C.J.L. The epidemiologic transition revisited: Compositional models for causes of death by age and sex. Popul Dev Rev 2002, 28(2):205-228.
13. Shkolnikov V., McKee M., Leon D. Changes in life expectancy in Russia in the mid-1990s. Lancet 2001, 357:917-921.
14. McKee M., Shkolnikov V. Understanding the toll of premature death among men in eastern Europe. BMJ 2001, 323:1051-1055.
15. Truelsen T., Begg S., Mathers C.D., Satoh T. Global burden of cerebrovascular disease in the year 2000 2002, World Health Organization, Geneva, Available at., Accessed 8 June 2008. Global burden of disease 2000 working paper. http://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestrok e.pdf.
16. Begg S., Vos T., Barker B., et al. The burden of disease and injury in Australia 2003 2007, Australian Institute of Health and Welfare, Canberra.
17. Lopez A, Phoolcharoen W, Vos T, et al: Burden of disease and cost-effectiveness of intervention options: Informing policy decisions and health system reform in Thailand. Wellcome Trust: NHMRC/Wellcome Trust International Collaborative Research Grant. Available at http:// . Accessed 29 Nov 2007. 2004. http://www.wellcome.ac.uk/doc_WTD003308.html.
18. Aekplakorn W., Abbott-Klafter J., Premgamone A., et al. Prevalence and management of diabetes and associated risk factors by regions of Thailand: Third National Health Examination Survey 2004. Diabetes Care 2007, 30(8):2007-2012.
19. Sudlow C.L.M., Warlow C.P. Comparable studies of the incidence of stroke and its pathological types. Results from an international collaboration. Stroke 1997, 28:491-499.
20. Lawes C.M., Vander Hoorn S., Law M.R., et al. High blood pressure. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors 2004, 281-390. World Health Organization, Geneva. M. Ezzati, A. Lopez, A. Rodgers, C.J.L. Murray (Eds.).
21. Mathers C.D., Vos T., Stevenson C. The burden of disease and injury in Australia 1999, Australian Institute of Health and Welfare (AIHW), Canberra.
22. Salomon J.A., Murray C.J.L. A multi-method approach to estimating health state valuations. Health Econ 2004, 13(3):281-290.
23. Stouthard M., Essink-Bot M., Bonsel G., et al. Disability weights for diseases in the Netherlands 1997, Department of Public Health, Erasmus University, Rotterdam.
24. Jette A.M. How measurement techniques influence estimates of disability in older populations. Soc Sci Med 1994, 38(7):937-942.
25. Ali S.M., Mulley G.P. Is the Barthel scale appropriate in non-industrialized countries? A view of rural Pakistan. Disabil Rehabil 1998, 20:195-199.
26. Murray C.J.L., Lopez A.D. On the comparable quantification of health risks: Lessons from the global burden of disease study. Epidemiology 1999, 10(5):594-605.
27. Ezzati M., Lopez A.D., Rodgers A., Murray C.J.L. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors 2004, World Health Organization, Geneva.
28. Strong K.L. WHO Global Infobase Team: The SuRF Report. Surveillance of chronic disease risk factors: Country level data and comparable estimates 2005, World Health Organization, Geneva.
29. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3(11):e442.
30. Mathers C.D., Salomon J.A., Ezzati M., et al. Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. Global burden of disease and risk factors 2006, 399-426. Oxford University Press, New York. A.D. Lopez, C.D. Mathers, M. Ezzati, C.J.L. Murray, D.T. Jamison (Eds.).
31. Murray C.J.L., Mathers C.D., Salomon J.A. Towards evidence-based public health. Health systems performance assessment: debates, methods and empiricism 2003, 715-726. World Health Organization, Geneva. C.J.L. Murray, D. Evans (Eds.).
32. Asplund K. What MONICA told us about stroke. Lancet Neurol 2005, 4:64-68.
33. Truelsen T., Mahonen M., Tolonen H., et al. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke 2003, 34:1346-1352.
34. Sarti C., Stegmayr B., Tolonen H., et al. Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project. Stroke 2003, 34:1833.
35. Whiteley W., Lindley R., Wardlaw J., Sandercock P. on behalf of the IST-3 Collaborative Group. Third International Stroke Trial. Int J Stroke 2006, 1:172-176.
36. Warlow C., Sudlow C., Dennis M., et al. Stroke. Lancet 2003, 362:2121-2122.
37. Chen Z.M., Sandercock P., Pan H.C., et al. Indications for early aspirin use in acute ischaemic stroke: A combined analysis of 40,000 randomised patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 2000, 31:240-249.
38. Mendis S., Abegunde D., Usuf S., et al. WHO study on prevention of recurrences of myocardial infarction and stroke (WHO-PREMISE). Bull World Health Organ 2005, 83:820-829.
39. World Health Organization Preventing chronic diseases: A vital investment: WHO global report 2005, World Health Organization, Geneva.
40. Mortality over the twentieth century in Australia: Trends and patterns in major causes of death 2006, Australian Institute of Health and Welfare, Australian Institute of Health and Welfare (AIHW), Canberra.
41. Murray C.J.L., Lauer J., Hutubessy R. Effectiveness and costs on interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular disease risk. Lancet 2003, 361:717-725.
42. Sargent R.P., Shepard R.M., Glantz S.A. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ 2004, 328:977-980.
43. Fichtenberg C.M., Glantz S.A. Association of the California tobacco control program with declines in cigarette consumption and mortality from heart disease. N Engl J Med 2000, 343(24):1772-1777.
44. Uusitalo U., Feskens E.J.M., Tuomilehto J., et al. Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey. BMJ 1996, 313:1044-1046.
45. Leth T., Jensen H.G., Mikkelsen A.E., Bysted A. The effects of regulation on trans fatty acid content in Danish food. Atheroscler Suppl 2006, 7:53-56.
46. Zatonski W.A., McMichael A.J., Powles J.W. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ 1998, 316(7137):1047-1051.
47. Dunn A.L., Andersen R.E., Jakicic J.M. Lifestyle physical activity interventions. History, short-and long-term effects and recommendations. Am J Prev Med 1998, 15(4):398-412.